Heat Biologics Inc. (HTBX) Declined -8.29% or -0.12 To Price $1.34 On Thursday


Heat Biologics Inc. (HTBX) declined -8.29% or -0.12 to $1.34. It is nearly 1.45 million shares traded, which is 287.46% compare to the average total volume 504412. The market cap of HTBX is $43.46 million. The year to date change is 29.45%. The 52 week price range is from $0.95 to $4.3. Price of HTBX have changed 5.04% during last week. It have changed 7.35% over last month, 2.82% over last 3 months, -21.51% over last 6 months and -51.33% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HTBX is 1.29. It is -3.73% below current price. The 200-day Moving Averages for HTBX is 1.78. It is 32.84% above current price. The 52-week High is 4.3. It is 220.90% from the current price. The 52-week Low is 0.95. It is -29.10% from current price.

There are some statistics of HTBX. It is has market cap $43.46 million. The share outstanding is 32.46 million. The average volume is 504412. The percent of top 15 Institution holding is 5.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HTBX is -85.46%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HTBX is -59.40%.


Tags:

Share this post